nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—PTGFR—ovarian follicle—obesity	0.127	0.698	CbGeAlD
Travoprost—PTGFR—respiratory system—obesity	0.0168	0.0921	CbGeAlD
Travoprost—PTGFR—adipose tissue—obesity	0.0113	0.0622	CbGeAlD
Travoprost—PTGFR—adrenal gland—obesity	0.0102	0.0558	CbGeAlD
Travoprost—PTGFR—endocrine gland—obesity	0.00882	0.0484	CbGeAlD
Travoprost—PTGFR—liver—obesity	0.00795	0.0436	CbGeAlD
Travoprost—Bimatoprost—AKR1C3—obesity	0.00628	0.525	CrCbGaD
Travoprost—Latanoprost—SLC22A1—obesity	0.00405	0.339	CrCbGaD
Travoprost—Tafluprost—PTGS2—obesity	0.00163	0.136	CrCbGaD
Travoprost—Diarrhoea—Phentermine—obesity	0.00106	0.0021	CcSEcCtD
Travoprost—Feeling abnormal—Cimetidine—obesity	0.00106	0.00209	CcSEcCtD
Travoprost—Asthma—Bupropion—obesity	0.00105	0.00208	CcSEcCtD
Travoprost—Influenza—Bupropion—obesity	0.00105	0.00208	CcSEcCtD
Travoprost—Conjunctivitis—Sibutramine—obesity	0.00104	0.00207	CcSEcCtD
Travoprost—Urinary tract infection—Sibutramine—obesity	0.00104	0.00207	CcSEcCtD
Travoprost—Sinusitis—Orlistat—obesity	0.00104	0.00206	CcSEcCtD
Travoprost—Urinary incontinence—Topiramate—obesity	0.00103	0.00204	CcSEcCtD
Travoprost—Dizziness—Phentermine—obesity	0.00102	0.00203	CcSEcCtD
Travoprost—Rash—Phenylpropanolamine—obesity	0.00102	0.00202	CcSEcCtD
Travoprost—Dermatitis—Phenylpropanolamine—obesity	0.00102	0.00202	CcSEcCtD
Travoprost—Bronchitis—Bupropion—obesity	0.00101	0.002	CcSEcCtD
Travoprost—Sinusitis—Sibutramine—obesity	0.00101	0.002	CcSEcCtD
Travoprost—Photophobia—Topiramate—obesity	0.001	0.00198	CcSEcCtD
Travoprost—Pharyngitis—Orlistat—obesity	0.000989	0.00196	CcSEcCtD
Travoprost—Dry eye—Topiramate—obesity	0.000985	0.00195	CcSEcCtD
Travoprost—Urinary tract disorder—Orlistat—obesity	0.000984	0.00195	CcSEcCtD
Travoprost—Dysuria—Bupropion—obesity	0.000982	0.00195	CcSEcCtD
Travoprost—Bradycardia—Sibutramine—obesity	0.000982	0.00195	CcSEcCtD
Travoprost—Urethral disorder—Orlistat—obesity	0.000977	0.00194	CcSEcCtD
Travoprost—Rash—Phentermine—obesity	0.000977	0.00194	CcSEcCtD
Travoprost—Dermatitis—Phentermine—obesity	0.000976	0.00193	CcSEcCtD
Travoprost—Headache—Phentermine—obesity	0.000971	0.00192	CcSEcCtD
Travoprost—Rhinitis—Sibutramine—obesity	0.000967	0.00192	CcSEcCtD
Travoprost—Nausea—Phenylpropanolamine—obesity	0.000962	0.00191	CcSEcCtD
Travoprost—Pharyngitis—Sibutramine—obesity	0.000957	0.0019	CcSEcCtD
Travoprost—Hypersensitivity—Cimetidine—obesity	0.000945	0.00187	CcSEcCtD
Travoprost—Infestation—Bupropion—obesity	0.000937	0.00186	CcSEcCtD
Travoprost—Infestation NOS—Bupropion—obesity	0.000937	0.00186	CcSEcCtD
Travoprost—Abnormal vision—Topiramate—obesity	0.00093	0.00184	CcSEcCtD
Travoprost—Visual impairment—Sibutramine—obesity	0.000929	0.00184	CcSEcCtD
Travoprost—Diarrhoea—Diethylpropion—obesity	0.000922	0.00183	CcSEcCtD
Travoprost—Nausea—Phentermine—obesity	0.00092	0.00182	CcSEcCtD
Travoprost—Asthenia—Cimetidine—obesity	0.00092	0.00182	CcSEcCtD
Travoprost—Conjunctivitis—Bupropion—obesity	0.00091	0.0018	CcSEcCtD
Travoprost—Urinary tract infection—Bupropion—obesity	0.00091	0.0018	CcSEcCtD
Travoprost—Eye disorder—Sibutramine—obesity	0.000901	0.00179	CcSEcCtD
Travoprost—Immune system disorder—Orlistat—obesity	0.0009	0.00178	CcSEcCtD
Travoprost—Tinnitus—Sibutramine—obesity	0.000899	0.00178	CcSEcCtD
Travoprost—Mediastinal disorder—Orlistat—obesity	0.000898	0.00178	CcSEcCtD
Travoprost—Dizziness—Diethylpropion—obesity	0.000891	0.00177	CcSEcCtD
Travoprost—Sinusitis—Bupropion—obesity	0.000879	0.00174	CcSEcCtD
Travoprost—Diarrhoea—Cimetidine—obesity	0.000878	0.00174	CcSEcCtD
Travoprost—Angiopathy—Sibutramine—obesity	0.000875	0.00173	CcSEcCtD
Travoprost—Mental disorder—Orlistat—obesity	0.000873	0.00173	CcSEcCtD
Travoprost—Immune system disorder—Sibutramine—obesity	0.000871	0.00173	CcSEcCtD
Travoprost—Eye pain—Topiramate—obesity	0.000858	0.0017	CcSEcCtD
Travoprost—Nasal congestion—Topiramate—obesity	0.00085	0.00168	CcSEcCtD
Travoprost—Rash—Diethylpropion—obesity	0.00085	0.00168	CcSEcCtD
Travoprost—Dysgeusia—Orlistat—obesity	0.00085	0.00168	CcSEcCtD
Travoprost—Dermatitis—Diethylpropion—obesity	0.000849	0.00168	CcSEcCtD
Travoprost—Dizziness—Cimetidine—obesity	0.000848	0.00168	CcSEcCtD
Travoprost—Headache—Diethylpropion—obesity	0.000844	0.00167	CcSEcCtD
Travoprost—Rhinitis—Bupropion—obesity	0.000843	0.00167	CcSEcCtD
Travoprost—Back pain—Orlistat—obesity	0.000839	0.00166	CcSEcCtD
Travoprost—Pharyngitis—Bupropion—obesity	0.000835	0.00165	CcSEcCtD
Travoprost—Urinary tract disorder—Bupropion—obesity	0.00083	0.00165	CcSEcCtD
Travoprost—Connective tissue disorder—Bupropion—obesity	0.000826	0.00164	CcSEcCtD
Travoprost—Urethral disorder—Bupropion—obesity	0.000824	0.00163	CcSEcCtD
Travoprost—Dysgeusia—Sibutramine—obesity	0.000822	0.00163	CcSEcCtD
Travoprost—Vision blurred—Orlistat—obesity	0.000818	0.00162	CcSEcCtD
Travoprost—Back pain—Sibutramine—obesity	0.000812	0.00161	CcSEcCtD
Travoprost—Visual impairment—Bupropion—obesity	0.00081	0.00161	CcSEcCtD
Travoprost—Rash—Cimetidine—obesity	0.000809	0.0016	CcSEcCtD
Travoprost—Dermatitis—Cimetidine—obesity	0.000808	0.0016	CcSEcCtD
Travoprost—Ill-defined disorder—Orlistat—obesity	0.000805	0.0016	CcSEcCtD
Travoprost—Headache—Cimetidine—obesity	0.000803	0.00159	CcSEcCtD
Travoprost—Nausea—Diethylpropion—obesity	0.000801	0.00159	CcSEcCtD
Travoprost—Vision blurred—Sibutramine—obesity	0.000791	0.00157	CcSEcCtD
Travoprost—Eye disorder—Bupropion—obesity	0.000786	0.00156	CcSEcCtD
Travoprost—Tinnitus—Bupropion—obesity	0.000784	0.00155	CcSEcCtD
Travoprost—Malaise—Orlistat—obesity	0.000782	0.00155	CcSEcCtD
Travoprost—Cardiac disorder—Bupropion—obesity	0.00078	0.00155	CcSEcCtD
Travoprost—Vertigo—Orlistat—obesity	0.000779	0.00154	CcSEcCtD
Travoprost—Ill-defined disorder—Sibutramine—obesity	0.000779	0.00154	CcSEcCtD
Travoprost—Palpitations—Orlistat—obesity	0.000767	0.00152	CcSEcCtD
Travoprost—Angiopathy—Bupropion—obesity	0.000763	0.00151	CcSEcCtD
Travoprost—Nausea—Cimetidine—obesity	0.000762	0.00151	CcSEcCtD
Travoprost—Immune system disorder—Bupropion—obesity	0.000759	0.00151	CcSEcCtD
Travoprost—Mediastinal disorder—Bupropion—obesity	0.000758	0.0015	CcSEcCtD
Travoprost—Malaise—Sibutramine—obesity	0.000757	0.0015	CcSEcCtD
Travoprost—Cough—Orlistat—obesity	0.000757	0.0015	CcSEcCtD
Travoprost—Vertigo—Sibutramine—obesity	0.000754	0.00149	CcSEcCtD
Travoprost—Palpitations—Sibutramine—obesity	0.000742	0.00147	CcSEcCtD
Travoprost—Myalgia—Orlistat—obesity	0.000739	0.00146	CcSEcCtD
Travoprost—Chest pain—Orlistat—obesity	0.000739	0.00146	CcSEcCtD
Travoprost—Mental disorder—Bupropion—obesity	0.000737	0.00146	CcSEcCtD
Travoprost—Anxiety—Orlistat—obesity	0.000736	0.00146	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000734	0.00145	CcSEcCtD
Travoprost—Cough—Sibutramine—obesity	0.000733	0.00145	CcSEcCtD
Travoprost—Discomfort—Orlistat—obesity	0.00073	0.00145	CcSEcCtD
Travoprost—Hypertension—Sibutramine—obesity	0.000725	0.00144	CcSEcCtD
Travoprost—Dry mouth—Orlistat—obesity	0.000722	0.00143	CcSEcCtD
Travoprost—Dysgeusia—Bupropion—obesity	0.000717	0.00142	CcSEcCtD
Travoprost—Chest pain—Sibutramine—obesity	0.000715	0.00142	CcSEcCtD
Travoprost—Myalgia—Sibutramine—obesity	0.000715	0.00142	CcSEcCtD
Travoprost—Arthralgia—Sibutramine—obesity	0.000715	0.00142	CcSEcCtD
Travoprost—Anxiety—Sibutramine—obesity	0.000712	0.00141	CcSEcCtD
Travoprost—Oedema—Orlistat—obesity	0.000708	0.0014	CcSEcCtD
Travoprost—Back pain—Bupropion—obesity	0.000708	0.0014	CcSEcCtD
Travoprost—Discomfort—Sibutramine—obesity	0.000706	0.0014	CcSEcCtD
Travoprost—Infection—Orlistat—obesity	0.000703	0.00139	CcSEcCtD
Travoprost—Dry mouth—Sibutramine—obesity	0.000699	0.00139	CcSEcCtD
Travoprost—Nervous system disorder—Orlistat—obesity	0.000694	0.00138	CcSEcCtD
Travoprost—Vision blurred—Bupropion—obesity	0.00069	0.00137	CcSEcCtD
Travoprost—Skin disorder—Orlistat—obesity	0.000688	0.00136	CcSEcCtD
Travoprost—Oedema—Sibutramine—obesity	0.000685	0.00136	CcSEcCtD
Travoprost—Infection—Sibutramine—obesity	0.000681	0.00135	CcSEcCtD
Travoprost—Ill-defined disorder—Bupropion—obesity	0.000679	0.00135	CcSEcCtD
Travoprost—Asthma—Topiramate—obesity	0.000669	0.00133	CcSEcCtD
Travoprost—Tachycardia—Sibutramine—obesity	0.000669	0.00133	CcSEcCtD
Travoprost—Skin disorder—Sibutramine—obesity	0.000666	0.00132	CcSEcCtD
Travoprost—Malaise—Bupropion—obesity	0.00066	0.00131	CcSEcCtD
Travoprost—Vertigo—Bupropion—obesity	0.000658	0.0013	CcSEcCtD
Travoprost—Angina pectoris—Topiramate—obesity	0.000652	0.00129	CcSEcCtD
Travoprost—Palpitations—Bupropion—obesity	0.000647	0.00128	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Orlistat—obesity	0.000645	0.00128	CcSEcCtD
Travoprost—Bronchitis—Topiramate—obesity	0.000644	0.00128	CcSEcCtD
Travoprost—Hypotension—Sibutramine—obesity	0.00064	0.00127	CcSEcCtD
Travoprost—Cough—Bupropion—obesity	0.000639	0.00127	CcSEcCtD
Travoprost—Hypertension—Bupropion—obesity	0.000632	0.00125	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—NPY5R—obesity	0.000629	0.00209	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—NMU—obesity	0.000629	0.00209	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HCRT—obesity	0.000629	0.00209	CbGpPWpGaD
Travoprost—Dysuria—Topiramate—obesity	0.000626	0.00124	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Sibutramine—obesity	0.000624	0.00124	CcSEcCtD
Travoprost—Dyspepsia—Orlistat—obesity	0.000623	0.00124	CcSEcCtD
Travoprost—Chest pain—Bupropion—obesity	0.000623	0.00123	CcSEcCtD
Travoprost—Myalgia—Bupropion—obesity	0.000623	0.00123	CcSEcCtD
Travoprost—Arthralgia—Bupropion—obesity	0.000623	0.00123	CcSEcCtD
Travoprost—Anxiety—Bupropion—obesity	0.000621	0.00123	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—obesity	0.000621	0.00206	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—ADRB2—obesity	0.00062	0.00206	CbGpPWpGaD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000619	0.00123	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—KIF7—obesity	0.000616	0.00205	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MKS1—obesity	0.000616	0.00205	CbGpPWpGaD
Travoprost—Discomfort—Bupropion—obesity	0.000616	0.00122	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—NPS—obesity	0.000613	0.00204	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Orlistat—obesity	0.000611	0.00121	CcSEcCtD
Travoprost—Dyspnoea—Sibutramine—obesity	0.000611	0.00121	CcSEcCtD
Travoprost—Fatigue—Orlistat—obesity	0.00061	0.00121	CcSEcCtD
Travoprost—Dry mouth—Bupropion—obesity	0.000609	0.00121	CcSEcCtD
Travoprost—Pain—Orlistat—obesity	0.000605	0.0012	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—NPY2R—obesity	0.000603	0.002	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—MC3R—obesity	0.000603	0.002	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—MC4R—obesity	0.000603	0.002	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—NPY1R—obesity	0.000603	0.002	CbGpPWpGaD
Travoprost—Dyspepsia—Sibutramine—obesity	0.000603	0.0012	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—DRD1—obesity	0.000601	0.002	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—HTR2C—obesity	0.000601	0.002	CbGpPWpGaD
Travoprost—Oedema—Bupropion—obesity	0.000597	0.00118	CcSEcCtD
Travoprost—Infestation NOS—Topiramate—obesity	0.000597	0.00118	CcSEcCtD
Travoprost—Infestation—Topiramate—obesity	0.000597	0.00118	CcSEcCtD
Travoprost—Depression—Topiramate—obesity	0.000595	0.00118	CcSEcCtD
Travoprost—Infection—Bupropion—obesity	0.000593	0.00118	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—PPY—obesity	0.000592	0.00196	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Sibutramine—obesity	0.000592	0.00117	CcSEcCtD
Travoprost—Pain—Sibutramine—obesity	0.000586	0.00116	CcSEcCtD
Travoprost—Constipation—Sibutramine—obesity	0.000586	0.00116	CcSEcCtD
Travoprost—Nervous system disorder—Bupropion—obesity	0.000586	0.00116	CcSEcCtD
Travoprost—Feeling abnormal—Orlistat—obesity	0.000583	0.00116	CcSEcCtD
Travoprost—Tachycardia—Bupropion—obesity	0.000583	0.00116	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ADRB1—obesity	0.000582	0.00193	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PRKCH—obesity	0.000581	0.00193	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GIP—obesity	0.000581	0.00193	CbGpPWpGaD
Travoprost—Skin disorder—Bupropion—obesity	0.00058	0.00115	CcSEcCtD
Travoprost—Conjunctivitis—Topiramate—obesity	0.00058	0.00115	CcSEcCtD
Travoprost—Urinary tract infection—Topiramate—obesity	0.00058	0.00115	CcSEcCtD
Travoprost—Gastrointestinal pain—Orlistat—obesity	0.000579	0.00115	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—obesity	0.000573	0.0019	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HCRT—obesity	0.000571	0.0019	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PMCH—obesity	0.000571	0.0019	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NMU—obesity	0.000571	0.0019	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY5R—obesity	0.000571	0.0019	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GHRL—obesity	0.00057	0.00189	CbGpPWpGaD
Travoprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—obesity	0.000565	0.00188	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—DRD4—obesity	0.000565	0.00188	CbGpPWpGaD
Travoprost—Feeling abnormal—Sibutramine—obesity	0.000565	0.00112	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PRLH—obesity	0.000563	0.00187	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Sibutramine—obesity	0.00056	0.00111	CcSEcCtD
Travoprost—Sinusitis—Topiramate—obesity	0.00056	0.00111	CcSEcCtD
Travoprost—Abdominal pain—Orlistat—obesity	0.00056	0.00111	CcSEcCtD
Travoprost—Hypotension—Bupropion—obesity	0.000558	0.00111	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—obesity	0.000549	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MC3R—obesity	0.000548	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—MC4R—obesity	0.000548	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY1R—obesity	0.000548	0.00182	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY2R—obesity	0.000548	0.00182	CbGpPWpGaD
Travoprost—Bradycardia—Topiramate—obesity	0.000545	0.00108	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Bupropion—obesity	0.000544	0.00108	CcSEcCtD
Travoprost—Abdominal pain—Sibutramine—obesity	0.000542	0.00107	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CNR1—obesity	0.00054	0.00179	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PPY—obesity	0.000537	0.00178	CbGpPWpGaD
Travoprost—Rhinitis—Topiramate—obesity	0.000537	0.00106	CcSEcCtD
Travoprost—Dyspnoea—Bupropion—obesity	0.000533	0.00106	CcSEcCtD
Travoprost—Pharyngitis—Topiramate—obesity	0.000532	0.00105	CcSEcCtD
Travoprost—Urinary tract disorder—Topiramate—obesity	0.000529	0.00105	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—PRKCH—obesity	0.000527	0.00175	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GIP—obesity	0.000527	0.00175	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—DRD2—obesity	0.000527	0.00175	CbGpPWpGaD
Travoprost—Connective tissue disorder—Topiramate—obesity	0.000526	0.00104	CcSEcCtD
Travoprost—Dyspepsia—Bupropion—obesity	0.000526	0.00104	CcSEcCtD
Travoprost—Urethral disorder—Topiramate—obesity	0.000525	0.00104	CcSEcCtD
Travoprost—Hypersensitivity—Orlistat—obesity	0.000522	0.00103	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—GCG—obesity	0.000521	0.00173	CbGpPWpGaD
Travoprost—Visual impairment—Topiramate—obesity	0.000516	0.00102	CcSEcCtD
Travoprost—Gastrointestinal disorder—Bupropion—obesity	0.000516	0.00102	CcSEcCtD
Travoprost—Fatigue—Bupropion—obesity	0.000515	0.00102	CcSEcCtD
Travoprost—Constipation—Bupropion—obesity	0.000511	0.00101	CcSEcCtD
Travoprost—Pain—Bupropion—obesity	0.000511	0.00101	CcSEcCtD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3R1—obesity	0.000509	0.00169	CbGpPWpGaD
Travoprost—Asthenia—Orlistat—obesity	0.000508	0.00101	CcSEcCtD
Travoprost—Hypersensitivity—Sibutramine—obesity	0.000505	0.001	CcSEcCtD
Travoprost—Pruritus—Orlistat—obesity	0.000501	0.000993	CcSEcCtD
Travoprost—Eye disorder—Topiramate—obesity	0.000501	0.000992	CcSEcCtD
Travoprost—Tinnitus—Topiramate—obesity	0.000499	0.00099	CcSEcCtD
Travoprost—Cardiac disorder—Topiramate—obesity	0.000497	0.000985	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—ADRB3—obesity	0.000494	0.00164	CbGpPWpGaD
Travoprost—Feeling abnormal—Bupropion—obesity	0.000492	0.000976	CcSEcCtD
Travoprost—Asthenia—Sibutramine—obesity	0.000492	0.000974	CcSEcCtD
Travoprost—Gastrointestinal pain—Bupropion—obesity	0.000488	0.000968	CcSEcCtD
Travoprost—Angiopathy—Topiramate—obesity	0.000486	0.000963	CcSEcCtD
Travoprost—Pruritus—Sibutramine—obesity	0.000485	0.000961	CcSEcCtD
Travoprost—Diarrhoea—Orlistat—obesity	0.000484	0.00096	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—obesity	0.000484	0.00161	CbGpPWpGaD
Travoprost—Immune system disorder—Topiramate—obesity	0.000484	0.000959	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—C3—obesity	0.000484	0.00161	CbGpPWpGaD
Travoprost—Mediastinal disorder—Topiramate—obesity	0.000483	0.000957	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GAL—obesity	0.000482	0.0016	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—C5AR1—obesity	0.000477	0.00158	CbGpPWpGaD
Travoprost—Abdominal pain—Bupropion—obesity	0.000472	0.000936	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—ADRB2—obesity	0.000472	0.00157	CbGpPWpGaD
Travoprost—Mental disorder—Topiramate—obesity	0.000469	0.00093	CcSEcCtD
Travoprost—Diarrhoea—Sibutramine—obesity	0.000469	0.000929	CcSEcCtD
Travoprost—Dizziness—Orlistat—obesity	0.000468	0.000928	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GHRH—obesity	0.000467	0.00155	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NMB—obesity	0.000467	0.00155	CbGpPWpGaD
Travoprost—Erythema—Topiramate—obesity	0.000466	0.000924	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—obesity	0.000464	0.00154	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—obesity	0.00046	0.00153	CbGpPWpGaD
Travoprost—Dysgeusia—Topiramate—obesity	0.000457	0.000905	CcSEcCtD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—obesity	0.000456	0.00151	CbGpPWpGaD
Travoprost—Dizziness—Sibutramine—obesity	0.000453	0.000898	CcSEcCtD
Travoprost—Back pain—Topiramate—obesity	0.000451	0.000894	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—GNB3—obesity	0.000449	0.00149	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB3—obesity	0.000448	0.00149	CbGpPWpGaD
Travoprost—Rash—Orlistat—obesity	0.000446	0.000885	CcSEcCtD
Travoprost—Dermatitis—Orlistat—obesity	0.000446	0.000884	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—FFAR4—obesity	0.000445	0.00148	CbGpPWpGaD
Travoprost—Headache—Orlistat—obesity	0.000444	0.000879	CcSEcCtD
Travoprost—Hypersensitivity—Bupropion—obesity	0.00044	0.000872	CcSEcCtD
Travoprost—Vision blurred—Topiramate—obesity	0.000439	0.000871	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GAL—obesity	0.000438	0.00145	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—GNAS—obesity	0.000437	0.00145	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCK—obesity	0.000436	0.00145	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—C5AR1—obesity	0.000433	0.00144	CbGpPWpGaD
Travoprost—Ill-defined disorder—Topiramate—obesity	0.000433	0.000858	CcSEcCtD
Travoprost—Rash—Sibutramine—obesity	0.000432	0.000856	CcSEcCtD
Travoprost—Dermatitis—Sibutramine—obesity	0.000432	0.000855	CcSEcCtD
Travoprost—Headache—Sibutramine—obesity	0.000429	0.000851	CcSEcCtD
Travoprost—Asthenia—Bupropion—obesity	0.000429	0.000849	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—BRS3—obesity	0.000427	0.00142	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MCHR1—obesity	0.000427	0.00142	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GHSR—obesity	0.000427	0.00142	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GLP1R—obesity	0.000425	0.00141	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000425	0.00141	CbGpPWpGaD
Travoprost—Pruritus—Bupropion—obesity	0.000423	0.000838	CcSEcCtD
Travoprost—Nausea—Orlistat—obesity	0.000421	0.000833	CcSEcCtD
Travoprost—Malaise—Topiramate—obesity	0.000421	0.000833	CcSEcCtD
Travoprost—Vertigo—Topiramate—obesity	0.000419	0.00083	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—CCL5—obesity	0.000418	0.00139	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CCKAR—obesity	0.000418	0.00139	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HRH3—obesity	0.000418	0.00139	CbGpPWpGaD
Travoprost—Palpitations—Topiramate—obesity	0.000412	0.000817	CcSEcCtD
Travoprost—Diarrhoea—Bupropion—obesity	0.000409	0.00081	CcSEcCtD
Travoprost—Nausea—Sibutramine—obesity	0.000407	0.000807	CcSEcCtD
Travoprost—Cough—Topiramate—obesity	0.000407	0.000806	CcSEcCtD
Travoprost—Hypertension—Topiramate—obesity	0.000403	0.000798	CcSEcCtD
Travoprost—Chest pain—Topiramate—obesity	0.000397	0.000787	CcSEcCtD
Travoprost—Arthralgia—Topiramate—obesity	0.000397	0.000787	CcSEcCtD
Travoprost—Myalgia—Topiramate—obesity	0.000397	0.000787	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—SH2B1—obesity	0.000397	0.00132	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GH1—obesity	0.000397	0.00132	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRLHR—obesity	0.000397	0.00132	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCK—obesity	0.000396	0.00131	CbGpPWpGaD
Travoprost—Anxiety—Topiramate—obesity	0.000396	0.000784	CcSEcCtD
Travoprost—Dizziness—Bupropion—obesity	0.000395	0.000783	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000394	0.000781	CcSEcCtD
Travoprost—Discomfort—Topiramate—obesity	0.000392	0.000777	CcSEcCtD
Travoprost—Dry mouth—Topiramate—obesity	0.000388	0.00077	CcSEcCtD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000387	0.00128	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GLP1R—obesity	0.000386	0.00128	CbGpPWpGaD
Travoprost—Oedema—Topiramate—obesity	0.000381	0.000754	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CCKAR—obesity	0.00038	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HRH3—obesity	0.00038	0.00126	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—NPY—obesity	0.000379	0.00126	CbGpPWpGaD
Travoprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000378	0.00126	CbGpPWpGaD
Travoprost—Infection—Topiramate—obesity	0.000378	0.000749	CcSEcCtD
Travoprost—Rash—Bupropion—obesity	0.000377	0.000746	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—IAPP—obesity	0.000376	0.00125	CbGpPWpGaD
Travoprost—Dermatitis—Bupropion—obesity	0.000376	0.000746	CcSEcCtD
Travoprost—Headache—Bupropion—obesity	0.000374	0.000742	CcSEcCtD
Travoprost—Nervous system disorder—Topiramate—obesity	0.000373	0.00074	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—APLN—obesity	0.000373	0.00124	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PYY—obesity	0.000373	0.00124	CbGpPWpGaD
Travoprost—Tachycardia—Topiramate—obesity	0.000371	0.000736	CcSEcCtD
Travoprost—Skin disorder—Topiramate—obesity	0.00037	0.000733	CcSEcCtD
Travoprost—PTGFR—GPCR ligand binding—HTR2A—obesity	0.000369	0.00122	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—C3—obesity	0.000368	0.00122	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRKAR2B—obesity	0.000366	0.00121	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HTR1B—obesity	0.000365	0.00121	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CRH—obesity	0.000365	0.00121	CbGpPWpGaD
Travoprost—Hypotension—Topiramate—obesity	0.000356	0.000705	CcSEcCtD
Travoprost—Nausea—Bupropion—obesity	0.000355	0.000703	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—PNLIP—obesity	0.000354	0.00117	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—AGT—obesity	0.00035	0.00116	CbGpPWpGaD
Travoprost—Musculoskeletal discomfort—Topiramate—obesity	0.000347	0.000687	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—NPS—obesity	0.000346	0.00115	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SDC3—obesity	0.000345	0.00115	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPY—obesity	0.000344	0.00114	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IAPP—obesity	0.000342	0.00114	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—DRD1—obesity	0.00034	0.00113	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HTR2C—obesity	0.00034	0.00113	CbGpPWpGaD
Travoprost—Dyspnoea—Topiramate—obesity	0.000339	0.000672	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HCRT—obesity	0.000338	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PMCH—obesity	0.000338	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPY5R—obesity	0.000338	0.00112	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NMU—obesity	0.000338	0.00112	CbGpPWpGaD
Travoprost—Dyspepsia—Topiramate—obesity	0.000335	0.000664	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—HTR1B—obesity	0.000332	0.0011	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CRH—obesity	0.000332	0.0011	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRB1—obesity	0.000329	0.00109	CbGpPWpGaD
Travoprost—Gastrointestinal disorder—Topiramate—obesity	0.000329	0.000651	CcSEcCtD
Travoprost—Fatigue—Topiramate—obesity	0.000328	0.00065	CcSEcCtD
Travoprost—Constipation—Topiramate—obesity	0.000325	0.000645	CcSEcCtD
Travoprost—Pain—Topiramate—obesity	0.000325	0.000645	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—NPY2R—obesity	0.000324	0.00107	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPY1R—obesity	0.000324	0.00107	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MC3R—obesity	0.000324	0.00107	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MC4R—obesity	0.000324	0.00107	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—F2—obesity	0.000323	0.00107	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GHRL—obesity	0.000322	0.00107	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—DRD4—obesity	0.000319	0.00106	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PPY—obesity	0.000317	0.00105	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—NPS—obesity	0.000315	0.00104	CbGpPWpGaD
Travoprost—Feeling abnormal—Topiramate—obesity	0.000314	0.000622	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—HDAC8—obesity	0.000312	0.00103	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCH—obesity	0.000312	0.00103	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GIP—obesity	0.000312	0.00103	CbGpPWpGaD
Travoprost—Gastrointestinal pain—Topiramate—obesity	0.000311	0.000617	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—DRD1—obesity	0.000309	0.00102	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HTR2C—obesity	0.000309	0.00102	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—CNR1—obesity	0.000305	0.00101	CbGpPWpGaD
Travoprost—Abdominal pain—Topiramate—obesity	0.000301	0.000596	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—ADRB1—obesity	0.000299	0.000992	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—DRD2—obesity	0.000298	0.000988	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LEPR—obesity	0.000296	0.000983	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GCG—obesity	0.000295	0.000978	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—POMC—obesity	0.000295	0.000978	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GHRL—obesity	0.000293	0.000971	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—DRD4—obesity	0.00029	0.000963	CbGpPWpGaD
Travoprost—PTGFR—GPCR ligand binding—CCL2—obesity	0.000288	0.000957	CbGpPWpGaD
Travoprost—PTGFR—G alpha (q) signalling events—PIK3CA—obesity	0.000287	0.000952	CbGpPWpGaD
Travoprost—Hypersensitivity—Topiramate—obesity	0.00028	0.000556	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—CNR1—obesity	0.000277	0.00092	CbGpPWpGaD
Travoprost—Asthenia—Topiramate—obesity	0.000273	0.000541	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—DRD2—obesity	0.00027	0.000897	CbGpPWpGaD
Travoprost—Pruritus—Topiramate—obesity	0.000269	0.000534	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GCG—obesity	0.000268	0.000888	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—ADRB2—obesity	0.000267	0.000885	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB3—obesity	0.000265	0.000879	CbGpPWpGaD
Travoprost—Diarrhoea—Topiramate—obesity	0.00026	0.000516	CcSEcCtD
Travoprost—PTGFR—Signaling Pathways—GAL—obesity	0.000259	0.000859	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—obesity	0.000256	0.000851	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—C5AR1—obesity	0.000256	0.000849	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—GNB3—obesity	0.000254	0.000843	CbGpPWpGaD
Travoprost—Dizziness—Topiramate—obesity	0.000252	0.000499	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—GNAS—obesity	0.000247	0.000821	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—ADRB2—obesity	0.000242	0.000804	CbGpPWpGaD
Travoprost—Rash—Topiramate—obesity	0.00024	0.000476	CcSEcCtD
Travoprost—Dermatitis—Topiramate—obesity	0.00024	0.000475	CcSEcCtD
Travoprost—Headache—Topiramate—obesity	0.000238	0.000473	CcSEcCtD
Travoprost—PTGFR—GPCR downstream signaling—CCL5—obesity	0.000236	0.000785	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKG1—obesity	0.000234	0.000777	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCK—obesity	0.000234	0.000777	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—GNB3—obesity	0.000231	0.000766	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GLP1R—obesity	0.000228	0.000757	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RBP4—obesity	0.000228	0.000757	CbGpPWpGaD
Travoprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—obesity	0.000227	0.000754	CbGpPWpGaD
Travoprost—Nausea—Topiramate—obesity	0.000226	0.000448	CcSEcCtD
Travoprost—PTGFR—Signaling by GPCR—GNAS—obesity	0.000225	0.000745	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCKAR—obesity	0.000224	0.000745	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HRH3—obesity	0.000224	0.000745	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKAR2B—obesity	0.000216	0.000717	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL5—obesity	0.000215	0.000713	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PRKCD—obesity	0.000213	0.000707	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NCF2—obesity	0.000209	0.000692	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—HTR2A—obesity	0.000208	0.000692	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—C3—obesity	0.000208	0.000691	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPY—obesity	0.000203	0.000675	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IAPP—obesity	0.000202	0.000671	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOC3—obesity	0.000202	0.000671	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AGT—obesity	0.000198	0.000657	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR1B—obesity	0.000196	0.000651	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CRH—obesity	0.000196	0.000651	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SDC1—obesity	0.000194	0.000644	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRKCD—obesity	0.000193	0.000642	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKR1C3—obesity	0.000191	0.000633	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—HTR2A—obesity	0.000189	0.000628	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—C3—obesity	0.000189	0.000628	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NPS—obesity	0.000186	0.000617	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—F2—obesity	0.000183	0.000607	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PRKCB—obesity	0.000183	0.000607	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2C—obesity	0.000182	0.000605	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DRD1—obesity	0.000182	0.000605	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AGT—obesity	0.00018	0.000596	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NTRK2—obesity	0.000177	0.000589	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB1—obesity	0.000177	0.000586	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CG—obesity	0.000175	0.000581	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PARP1—obesity	0.000173	0.000574	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GHRL—obesity	0.000173	0.000574	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DRD4—obesity	0.000171	0.000569	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—POMC—obesity	0.000166	0.000553	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PRKCB—obesity	0.000166	0.000551	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—F2—obesity	0.000166	0.000551	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CNR1—obesity	0.000164	0.000543	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TCF7L2—obesity	0.000161	0.000534	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT2—obesity	0.00016	0.000531	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—DRD2—obesity	0.00016	0.00053	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CG—obesity	0.000159	0.000527	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PTPN1—obesity	0.000158	0.000525	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GCG—obesity	0.000158	0.000525	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CD—obesity	0.000154	0.00051	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—POMC—obesity	0.000151	0.000502	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRL—obesity	0.000151	0.000501	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STK11—obesity	0.000149	0.000493	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—CCL2—obesity	0.000148	0.000491	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PLG—obesity	0.000147	0.000488	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—RHOA—obesity	0.000147	0.000487	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT2—obesity	0.000145	0.000482	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3R1—obesity	0.000145	0.000482	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FOXO3—obesity	0.000143	0.000476	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ADRB2—obesity	0.000143	0.000475	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SOCS1—obesity	0.000141	0.000468	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CD—obesity	0.00014	0.000464	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SOCS3—obesity	0.000139	0.000462	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GNB3—obesity	0.000136	0.000452	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—TYK2—obesity	0.000134	0.000446	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CB—obesity	0.000134	0.000445	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF2—obesity	0.000134	0.000444	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—RHOA—obesity	0.000133	0.000442	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—GNAS—obesity	0.000133	0.00044	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3R1—obesity	0.000132	0.000438	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOB—obesity	0.00013	0.000431	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL5—obesity	0.000127	0.000421	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LPL—obesity	0.000124	0.000412	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—FOXO1—obesity	0.000123	0.000409	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RPS6KB1—obesity	0.000123	0.000408	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CB—obesity	0.000122	0.000404	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCD—obesity	0.000114	0.000379	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—HTR2A—obesity	0.000112	0.000371	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—C3—obesity	0.000112	0.000371	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IRS2—obesity	0.000106	0.000353	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AGT—obesity	0.000106	0.000352	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—LEP—obesity	0.000104	0.000345	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOE—obesity	0.000104	0.000345	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CAV1—obesity	0.000103	0.000342	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—APOA1—obesity	0.000103	0.000341	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—ESR1—obesity	9.92e-05	0.000329	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PRKCB—obesity	9.8e-05	0.000325	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—F2—obesity	9.8e-05	0.000325	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—BAD—obesity	9.69e-05	0.000322	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CG—obesity	9.38e-05	0.000311	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IRS1—obesity	9.27e-05	0.000308	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—POMC—obesity	8.93e-05	0.000296	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—INS—obesity	8.88e-05	0.000295	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—CCL2—obesity	8.74e-05	0.00029	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IGF1—obesity	8.59e-05	0.000285	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT2—obesity	8.58e-05	0.000285	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CD—obesity	8.25e-05	0.000274	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—PIK3CA—obesity	8.17e-05	0.000271	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—SERPINE1—obesity	8.16e-05	0.000271	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TYK2—obesity	7.93e-05	0.000263	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—RHOA—obesity	7.87e-05	0.000261	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3R1—obesity	7.79e-05	0.000259	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—NOS3—obesity	7.79e-05	0.000259	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—PIK3CA—obesity	7.42e-05	0.000246	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CB—obesity	7.19e-05	0.000239	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MTOR—obesity	7.19e-05	0.000239	CbGpPWpGaD
Travoprost—PTGFR—GPCR downstream signaling—AKT1—obesity	6.67e-05	0.000222	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—IL6—obesity	6.57e-05	0.000218	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MMP9—obesity	6.25e-05	0.000207	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MAPK8—obesity	6.08e-05	0.000202	CbGpPWpGaD
Travoprost—PTGFR—Signaling by GPCR—AKT1—obesity	6.06e-05	0.000201	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—STAT3—obesity	5.56e-05	0.000184	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—MYC—obesity	5.16e-05	0.000171	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—TGFB1—obesity	5.15e-05	0.000171	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—PIK3CA—obesity	4.38e-05	0.000145	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—IL6—obesity	3.88e-05	0.000129	CbGpPWpGaD
Travoprost—PTGFR—Signaling Pathways—AKT1—obesity	3.58e-05	0.000119	CbGpPWpGaD
